Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Fluorescent Imaging in Medicinal Chemistry

BuchGebunden
228 Seiten
Englisch
Springererschienen am29.05.20201st ed. 2020
This book reviews the most recent developments of fluorescent imaging techniques for medicinal chemistry research and biomedical applications, including cell imaging, in vitro diagnosis and in vivo imaging.Fluorescent imaging techniques play an important role in basic research, drug discovery and clinical translation.mehr
Verfügbare Formate
BuchGebunden
EUR406,59
BuchKartoniert, Paperback
EUR406,59
E-BookPDF1 - PDF WatermarkE-Book
EUR394,83

Produkt

KlappentextThis book reviews the most recent developments of fluorescent imaging techniques for medicinal chemistry research and biomedical applications, including cell imaging, in vitro diagnosis and in vivo imaging.Fluorescent imaging techniques play an important role in basic research, drug discovery and clinical translation.
Details
ISBN/GTIN978-3-030-46706-7
ProduktartBuch
EinbandartGebunden
Verlag
Erscheinungsjahr2020
Erscheinungsdatum29.05.2020
Auflage1st ed. 2020
Seiten228 Seiten
SpracheEnglisch
Gewicht512 g
IllustrationenVII, 228 p. 1 illus.
Artikel-Nr.47966579

Inhalt/Kritik

Inhaltsverzeichnis
Fluorescence Molecular Imaging of Medicinal Chemistry in Cancer.- Organic Fluorescent Probes for Diagnostics and Bio-Imaging.- Inorganic Fluorescent Nanomaterials.- NIR-II fluorescent imaging.- X-Ray Excited Fluorescent Materials for Medical Application.- Fluorescent reporters for drug discovery.- Fluorescent Probes for Diagnostics of β-Galactosidase: From Micro to Macro.- The Present and Future of Optical Imaging Technologies in the Clinic: Diagnosis and Therapy.mehr

Schlagworte

Autor

Dr. Zhen Cheng is Associate Professor of Radiology and a member of the Molecular Imaging Program at Stanford (MIPS), BioX program, Canary Center at Stanford for Cancer Early Detection, and Stanford Cancer Center. He currently leads the Cancer Molecular Imaging Chemistry Laboratory (CMICL) of the MIPS, where he is developing novel molecular probes, non-invasive imaging techniques and bionanotechnology for the early detection and treatment of cancer. Dr. Cheng earned his PhD in Chemistry from University of Missouri-Columbia in 2001 and completed his post-doc training at Harvard Medical School in 2003. Dr. Cheng has published over 200 peer-reviewed articles. He has served as a reviewer for several funding agencies including NIH, DOD, DOE, etc. and also as an active reviewer for over 100 research journals.
Weitere Artikel von
Herausgegeben:Cheng, Zhen